8:30 am Registration & Coffee

8:45 am Chair’s Opening Remarks

Integrating ESG into Business Strategy for Sustainable Value Creation

9:00 am Presentation: Sustainable Horizons: Refining Business Strategy Across Life Sciences Organisations

• Veronique Toully Senior Vice President & Global Head of Sustainability, Corporate Affairs & Risks, UCB S.A.

Demystifying Fast-Paced Evolutions of the Regulatory Landscape & CSRD Compliance

9:30 am Presentation: Journey to CSRD Compliance: Regulatory Updates, Challenges & Practical Solutions in Europe

• Gareth Collins Vice President EHS & Environmental Sustainability, Ipsen Pharma

10:00 am Panel Discussion: Transforming Rivalries into Strategic Alliances for Successful Partnerships

• Veronique Toully Senior Vice President & Global Head of Sustainability, Corporate Affairs & Risks, UCB S.A.
• Guillermo Angeleri Senior Manager - Environmental, Social & Governance, Centrient Pharmaceuticals
• Andrea Cirlicova Global Scope 3 and Supplier Engagement Lead, Environmental Sustainability, Novartis AG

10:45 am Morning Refreshments & Networking

11:45 am Presentation: Translating Our Narrative From Strategy to Compliance in the European Regulatory Landscape

• Christoffer Falkman ESG Director, Bavarian Nordic

12:15 pm Lunch

1:15 pm Panel Discussion: Discovering Incentives for Biopharmaceuticals to Encourage Sustainable Performance

• Anne Frost ESG and Reporting Director, Kyowa Kirin Pharma
• Gareth Collins Vice President EHS & Environmental Sustainability, Ipsen Pharma
• Christoffer Falkman ESG Director, Bavarian Nordic

Streamlining Sustainable Data Collection & Reporting Processes

2:00 pm Presentation: Identifying & Driving Major Sources of Carbon Footprint in the Life Sciences Industry

• Matteo Alaria Head of Sustainability BPS, Sartorius

ESG Roundtable Discussions

2:30 pm In this interactive session, pick a roundtable to deep dive into discussion moderated by an expert in the E, S, or G space.

• Byron Austin Executive Director, Global Head, ESG, Sustainability, and Corporate Responsibility, Organon Pharmaceuticals
• Arun Skaria Senior Director, Corporate Responsibility and ESG, Alnylam Pharmaceuticals

Roundtable 1: ‘E’ Breaking the Plastic Habit to Advance Towards Zero Single-Use Plastics

Roundtable 2: ‘S’ Evaluating Strategy & Metrics to Ensure Effective Social Impact Measurement

• Arun Skaria Senior Director, Corporate Responsibility and ESG, Alnylam Pharmaceuticals

Roundtable 3: ‘G’ Engaging with the Board to Ensure Governance of Environmental & Social Pillars

3:30 pm Chair’s Closing Remarks & End of Conference Day One